SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-20-000045
Filing Date
2020-10-30
Accepted
2020-10-29 21:28:30
Documents
93
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q - PCRX - 9.30.2020 pcrx-20200930.htm   iXBRL 10-Q 1896325
2 EX-31.1 pcrx-9302020xex311.htm EX-31.1 11895
3 EX-31.2 pcrx-9302020xex312.htm EX-31.2 11904
4 EX-32.1 pcrx-9302020xex321.htm EX-32.1 7572
10 PACIRA BIOSCIENCES LOGO pcrx-20200930_g1.jpg GRAPHIC 27796
  Complete submission text file 0001396814-20-000045.txt   9388016

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20200930.xsd EX-101.SCH 60191
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20200930_cal.xml EX-101.CAL 110126
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20200930_def.xml EX-101.DEF 374722
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20200930_lab.xml EX-101.LAB 776062
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20200930_pre.xml EX-101.PRE 523278
11 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20200930_htm.xml XML 1667297
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 201274501
SIC: 2834 Pharmaceutical Preparations